JP2024538787A5 - - Google Patents
Info
- Publication number
- JP2024538787A5 JP2024538787A5 JP2024522356A JP2024522356A JP2024538787A5 JP 2024538787 A5 JP2024538787 A5 JP 2024538787A5 JP 2024522356 A JP2024522356 A JP 2024522356A JP 2024522356 A JP2024522356 A JP 2024522356A JP 2024538787 A5 JP2024538787 A5 JP 2024538787A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- isolated antibody
- antibody according
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306438.9 | 2021-10-14 | ||
| EP21306438 | 2021-10-14 | ||
| PCT/EP2022/078728 WO2023062226A2 (en) | 2021-10-14 | 2022-10-14 | Antibodies against extracellular epitopes of human trpv6 channel and their diagnostic and therapeutic uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538787A JP2024538787A (ja) | 2024-10-23 |
| JP2024538787A5 true JP2024538787A5 (enExample) | 2025-07-04 |
Family
ID=78820597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522356A Pending JP2024538787A (ja) | 2021-10-14 | 2022-10-14 | ヒトｔｒｐｖ６チャネルの細胞外エピトープに対する抗体並びにこれらの診断的及び治療的使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250236666A1 (enExample) |
| EP (1) | EP4416181A2 (enExample) |
| JP (1) | JP2024538787A (enExample) |
| KR (1) | KR20240099277A (enExample) |
| CN (1) | CN118401554A (enExample) |
| AU (1) | AU2022365387A1 (enExample) |
| CA (1) | CA3235233A1 (enExample) |
| WO (1) | WO2023062226A2 (enExample) |
| ZA (1) | ZA202403415B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260116965A1 (en) * | 2021-01-15 | 2026-04-30 | Coherent Biopharma (Suzhou) , Limited | Anti-trpv6 monoclonal antibody and application thereof |
| CN120590523B (zh) * | 2025-06-20 | 2026-01-27 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 一种犬瘟热病毒n蛋白单克隆抗体，快速检测胶体金试纸条及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005119262A2 (en) * | 2004-05-27 | 2005-12-15 | Galapagos N.V. | Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| JP5749154B2 (ja) | 2008-03-19 | 2015-07-15 | ソリシメド・バイオファーマ・インコーポレーテッド | Ｔｒｐｖ６カルシウムチャネル活性阻害による癌治療のためのペプチド組成物 |
| EP2445932B1 (en) * | 2009-06-26 | 2018-02-28 | Soricimed Biopharma Inc. | Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery |
| US20260116965A1 (en) * | 2021-01-15 | 2026-04-30 | Coherent Biopharma (Suzhou) , Limited | Anti-trpv6 monoclonal antibody and application thereof |
-
2022
- 2022-10-14 AU AU2022365387A patent/AU2022365387A1/en active Pending
- 2022-10-14 CN CN202280080017.5A patent/CN118401554A/zh active Pending
- 2022-10-14 WO PCT/EP2022/078728 patent/WO2023062226A2/en not_active Ceased
- 2022-10-14 CA CA3235233A patent/CA3235233A1/en active Pending
- 2022-10-14 US US18/700,859 patent/US20250236666A1/en active Pending
- 2022-10-14 EP EP22803215.7A patent/EP4416181A2/en active Pending
- 2022-10-14 JP JP2024522356A patent/JP2024538787A/ja active Pending
- 2022-10-14 KR KR1020247015775A patent/KR20240099277A/ko active Pending
-
2024
- 2024-05-02 ZA ZA2024/03415A patent/ZA202403415B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110407941B (zh) | Cd39的高亲和力抗体及其用途 | |
| CN108473575B (zh) | 抗-bcma多肽和蛋白质 | |
| ES2539045T3 (es) | Anticuerpos anti-KIR3D | |
| JP2022508747A (ja) | 新規抗－ｃ－ｋｉｔ抗体 | |
| CN109422811A (zh) | 抗cd47抗体及其用途 | |
| WO2017071625A1 (zh) | 一种抗pd-1单克隆抗体、其药物组合物及其用途 | |
| CN106699891A (zh) | 一种抗pd‑l1 抗体、其药物组合物及其用途 | |
| CN108456251A (zh) | 抗pd-l1抗体及其应用 | |
| JP7533897B2 (ja) | 融合タンパク質およびその使用 | |
| KR102107963B1 (ko) | 탄산탈수소 효소에 결합하는 항체 및 이의 용도 | |
| JP2024538787A5 (enExample) | ||
| KR102486507B1 (ko) | 플렉틴-1 결합 항체 및 그의 용도 | |
| WO2024046384A1 (zh) | 结合促甲状腺激素受体的抗体及其用途 | |
| US10822418B2 (en) | Fibrosis suppression by inhibiting integrin α-8 β-1 function | |
| CN112661855B (zh) | 含SIRPa变体的融合蛋白 | |
| US20240026025A1 (en) | Humanized anti-n-cadherin antibodies and uses thereof | |
| KR102665886B1 (ko) | Api5에 특이적으로 결합하는 항체 및 이의 용도 | |
| WO2018233333A9 (zh) | 一种靶向人肿瘤干细胞的单克隆抗体及其应用 | |
| CN102282172A (zh) | 抗伸展的ⅰ型鞘糖脂抗体、其衍生物以及用途 | |
| RU2024112807A (ru) | Антитела против внеклеточных эпитопов канала trpv6 человека и их диагностическое и терапевтическое применение, область техники, к которой относится изобретение | |
| EP4706676A1 (en) | Cysteine-engineered antigen-binding domains | |
| US20190256609A1 (en) | Novel monoclonal antibodies prevent cell surface protein shedding and block tumor growth | |
| KR101856904B1 (ko) | Pauf 단백질에 특이적으로 결합하는 항체 및 이의 용도 | |
| WO2024199468A1 (zh) | 双特异性抗体、药物组合物及用途 | |
| WO2024077775A1 (zh) | 一种多功能重组抗体及其制备方法和应用 |